NCT03308643

Brief Summary

To evaluate the effects of oxytocin infusion during abdominal myomectomy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for phase_4

Timeline
Completed

Started Oct 2017

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2017

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

October 9, 2017

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 12, 2017

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 10, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 10, 2018

Completed
Last Updated

May 21, 2018

Status Verified

May 1, 2018

Enrollment Period

7 months

First QC Date

October 9, 2017

Last Update Submit

May 17, 2018

Conditions

Keywords

myomectomyoxytocinblood loss

Outcome Measures

Primary Outcomes (1)

  • Blood loss during surgery

    estimated blood loss during the surgery measured by aspiration fluid.

    2 hours

Secondary Outcomes (1)

  • Blood loss after abdominal myomectomy

    1 hour postoperatively

Study Arms (2)

Oxytocin infusion

EXPERIMENTAL

Patients will receive intravenous oxytocin infusion just before the surgery after the induction of general anesthesia.

Drug: Oxytocin

Placebo

PLACEBO COMPARATOR

Patients will receive pure normal saline infusion at the same rate and volume just before the surgery after the induction of general anesthesia.

Other: saline

Interventions

Patients will receive intravenous oxytocin infusion just before the surgery after the induction of general anesthesia.

Oxytocin infusion
salineOTHER

Patients will receive intravenous normal saline infusion just before the surgery after the induction of general anesthesia.

Placebo

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsFemale patients with uterus and undergoing abdominal myomectomy
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Age 18-50
  • Patients who are candidate for abdominal myomectomy

You may not qualify if:

  • History of previous myomectomy.
  • Suspected malignancy
  • Patients with preoperative anemia
  • Patients using hormonal treatments before the surgery.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kanuni Sultan Suleyman Egitim ve Arastırma Hastanesi

Istanbul, Turkey (Türkiye)

Location

Related Publications (2)

  • Atashkhoei S, Fakhari S, Pourfathi H, Bilehjani E, Garabaghi PM, Asiaei A. Effect of oxytocin infusion on reducing the blood loss during abdominal myomectomy: a double-blind randomised controlled trial. BJOG. 2017 Jan;124(2):292-298. doi: 10.1111/1471-0528.14416. Epub 2016 Nov 15.

  • Chang FW, Yu MH, Ku CH, Chen CH, Wu GJ, Liu JY. Effect of uterotonics on intra-operative blood loss during laparoscopy-assisted vaginal hysterectomy: a randomised controlled trial. BJOG. 2006 Jan;113(1):47-52. doi: 10.1111/j.1471-0528.2005.00804.x.

MeSH Terms

Conditions

Hemorrhage

Interventions

OxytocinSodium Chloride

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Pituitary Hormones, PosteriorPituitary HormonesPeptide HormonesHormonesHormones, Hormone Substitutes, and Hormone AntagonistsPeptidesAmino Acids, Peptides, and ProteinsChloridesHydrochloric AcidChlorine CompoundsInorganic ChemicalsSodium Compounds

Study Officials

  • Berna Aslan

    Kanuni Sultan Suleyman Research and Training Hospital

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
Randomization will be performed by an online software and the list will be given to anesthesiologist so that neither the surgeon nor patient will know which intervention was performed. Randomized cards will be in sealed envelopes and will be open by anesthesiologist at the time of surgery.
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: The abdominal myomectomy cases will be randomized into 2 separate groups in a parallel fashion using an online software at 1:1 ratio.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Attending physician,ObGyn

Study Record Dates

First Submitted

October 9, 2017

First Posted

October 12, 2017

Study Start

October 1, 2017

Primary Completion

May 10, 2018

Study Completion

May 10, 2018

Last Updated

May 21, 2018

Record last verified: 2018-05

Locations